FINWIRES · TerminalLIVE
FINWIRES

Oman, Botswana Deepen Energy Ties with Fuel Security, Solar Projects

-- Oman and Botswana have signed a series of agreements to expand cooperation in fuel security, energy infrastructure, and renewable power development, the Omani Foreign Ministry said in a statement on Monday.

A key deal brings together OQ, Oman's state-owned integrated energy company, and Botswana Oil, Botswana's state-owned entity responsible for fuel procurement, storage, and national supply management. The two sides will assess the feasibility of developing integrated fuel supply and storage systems to strengthen Botswana's long-term energy security.

"OQ and Botswana Oil will assess the feasibility of creating an integrated platform combining coastal import and storage solutions with inland strategic stocks-a model intended to solidify security of supply and improve supply chain efficiency in order to meet Botswana's long-term fuel needs," the statement said.

The initiative builds on a 2025 cooperation framework covering technical, commercial and regulatory coordination. Early-stage work will focus on validating feasibility assumptions, determining strategic stock levels, and evaluating supply options.

In parallel, renewable energy cooperation is advancing. O-Green has signed a power purchase agreement with Botswana Power Corporation to develop a 500-megawatt solar photovoltaic plant in Maun, supported by a 500-MW battery energy storage system.

The project is the first to move into execution under a broader 3,000-MW energy cooperation framework agreed in 2025. It is expected to significantly expand Botswana's generation capacity and improve grid stability through large-scale energy storage.

Botswana aims to generate 50% of its electricity from renewable sources by 2030, reducing dependence on imports.

The package also includes further cooperation in petroleum storage infrastructure and broader collaboration across solar, wind and hydrocarbons, combining immediate energy security needs with long-term decarbonization goals.

相关文章

Australia

再生元公司称,FDA已加速批准其治疗遗传性听力损失的疗法

再生元公司(Regeneron,股票代码:REGN)周四宣布,美国食品药品监督管理局(FDA)已加速批准其治疗OTOF基因相关听力损失的药物Otarmeni用于治疗儿童和成人患者。 根据一份声明,FDA的批准基于正在进行的Chord试验。该试验显示,20名受试者中有16名在纯音测听评估中听力有所改善,其中14名表现出听觉脑干反应。 再生元公司表示,Otarmeni的持续批准可能取决于Chord试验验证性部分中临床获益的验证和描述。 该公司表示,将为美国符合临床条件的患者免费提供Otarmeni。 该公司股价周四上涨2%。Price: $761.47, Change: $+14.89, Percent Change: +1.99%

$REGN
Sectors

行业动态:医疗保健

周四下午,医疗保健类股下跌,纽约证券交易所医疗保健指数下跌0.5%,道富医疗保健精选行业SPDR ETF (XLV)下跌0.7%。 iShares生物技术ETF (IBB)下跌1.9%。 公司新闻方面,赛默飞世尔科技(TMO)周四上调了全年业绩预期,原因是其第一季度业绩强于预期,尽管内生增长低于分析师预期。该公司股价下跌10.9%。

$TMO
Research

美国银行称,德州仪器将受益于工业复苏和数据中心需求增长。

美国银行周四发布的一份报告指出,德州仪器 (TXN) 有望受益于工业复苏,尤其是在航空航天/国防、数据中心需求以及其美国本土制造业务带来的收益增长。 该券商还表示,随着德州仪器逐步摆脱大规模资本支出周期,其自由现金流有望更加强劲。报告还指出,德州仪器能够利用过去三年在美国晶圆厂的巨额资本支出,在“资源受限”的芯片市场中抢占市场份额。 美国银行还表示,看好德州仪器在直流电源领域的定位,该公司“在机架级产品中占据主导地位,并且随着架构向更高电压/更高功率密度系统发展,其专用插座业务也呈现增长势头”。 然而,美国银行指出,持续的地缘政治动荡仍然是整个行业面临的风险,但补充说,德州仪器历来具有相对更强的防御性。 美国银行将该股评级从“中性”上调至“买入”,并将目标价从 235 美元上调至 320 美元。Price: $283.62, Change: $+47.31, Percent Change: +20.02%

$TXN